Friday 31 January

Please note that this is the preliminary programma; times and titles are still subject to change

07.00 – 08.00               Breakfast session for ECRs (NextGen DLB)
                                     

08.30 - 09.00                Plenary V - Brain first vs body first in LBD
                                        Per Borghammer (Aarhus, Denmark)

09.00 - 09.30               Plenary VI - Drug trials and novel targets in DLB
                                        Dag Aarsland (London, UK)

09.30 - 09.45              SHORT BREAK

09.45 - 10.30                 Rising Star Awards

                                     ECR – Initiatives around the globe 

10.30 - 11.00                COFFEE

11.00 - 12.30                  Symposium VII - Outcome measure & Care
                                       Chairs: Joe Kane & Tanis Ferman

Oral presentations:
Elie Matar - The utility of composite endpoints for tracking disease progression in Lewy body dementia
Joseph Kane - An update on the Lewy Body Dementia Domain rating scale (LBD-DRS
Joseph Kane - A standardised approach to outcome measurement in dementia with Lewy bodies: Core Outcome Set (COS) development
Leah Forsberg - LBD Caregiver Preferences for Peer-to-Peer Support in the Connect2Caregiver Research Study Cohort
João Durães - "Comparing the diagnostic accuracy of different cognitive fluctuations scales for discriminating between Dementia with Lewy Bodies and Alzheimer's Disease"
Iracema Leroi - Developing an integrated care pathway (ICP) for Lewy Body Disease in Ireland

12.30 - 14.00               LUNCH/ Poster session

14.00 - 15.30                 Symposium VIII - Therapeutics in DLB
                                       Chairs: Jim Galvin & Manabu Ikeda

Oral presentations:
Lawrence Honig - Efficacy and safety results of the RewinD-LB phase 2b clinical trial of neflamapimod in dementia with Lewy bodies (DLB)
Charbel Moussa - "Cognitive and behavioral outcomes in patients with dementia with Lewy bodies treated with nilotinib"
Paula Sinead Donnelly - What matters most? Exploring the treatment preferences of people with dementia with Lewy bodies and their care partners: a stated preference study
James Galvin - Results from COG1201: A Proof-of-Concept Study of CT1812 in Participants with Mild-to-Moderate Dementia with Lewy Bodies
Anita D'Anselmo - tACS and its Influence on Cognitive Performance and Alpha Oscillations in Dementia with Lewy Bodies

15.30 - 16.00                 Debate (TBD) 

16.00 - 16.15                  Closing